NCT00118833View on ClinicalTrials.gov

St. John's Wort for the Treatment of Generalized Social Anxiety Disorder (GSAD)

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

August 31, 2002

Study Completion Date

June 30, 2006

Conditions
Anxiety DisordersMental Health
Interventions
DRUG

Hypericum perforatum (St. John's wort)

Trial Locations (1)

27710

Duke University Medical Center, Durham

All Listed Sponsors
lead

National Center for Complementary and Integrative Health (NCCIH)

NIH

NCT00118833 - St. John's Wort for the Treatment of Generalized Social Anxiety Disorder (GSAD) | Biotech Hunter | Biotech Hunter